NFKB1 and cancer: AIM suppressed TNF-α effects on the NF-κB-regulated proteins involved in cancer cell proliferation (COX-2, and C-myc), invasion, and angiogenesis (MMP-2 and MMP9, ICAM-1 and VEGF).